Obe-cel in Adolescent [Applicable in UK Only] and Adult Severe, Refractory Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Belimumab in SLE Synovial Inflammation and Lymph Nodes
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE1
Fatigue in Lupus Intervention Programmes (FLIP)
- Status
- RECRUITING
- Phase
- NA
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus.
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE
- Status
- RECRUITING
- Phase
- NA
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus
- Status
- WITHDRAWN
- Phase
- PHASE1
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
The Role of Some Hematological Parameters in Juvenile Systemic Lupue Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
fMRI Study of Early Brain Injury in Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants
- Status
- SUSPENDED
- Phase
- PHASE1
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A